AEMDAETHLON MEDICAL INC · NASDAQ Capital Market
Effective Supply — the real overhang

From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.

694.6K
Reported Float
512.6K
Tradeable Now
(estimated float)
▲ data says 694.6Koverstated 35%
1.51M
Effective Supply
3.18M
Fully Diluted
Dilution risk8/10
CONFIDENCE: MEDIUM
HIGHAssessed Aug 4, 2026Trigger: Reverse splitCRITICALNear-zero-strike pre-funded warrant overhang exercisable nowCRITICALAt-the-money warrant overhang unlocking on stockholder approval

Pending supply is roughly 494% of the estimated tradeable float. The dominant mechanism is approximately 1,001,600 post-split pre-funded warrants struck at $0.005 — economically zero-strike, registered, immediately exercisable with no stockholder approval required, equal to ~195% of the float. Exercise activity is already demonstrated: the share count went from 2,633,560 to 3,249,569 pre-split in the sixteen days after the July 7 closing. Layered on top are 1,126,602 common warrants at $3.55 against a $3.52 market price — dead at-the-money — that unlock the moment stockholder approval is obtained, with the meeting mandated no later than 2026-10-01. There are no convertible notes or preferred stock, and the Company is contractually barred for one year from issuing variable-rate or price-reset securities, which caps the true death-spiral scenario; the pre-funded warrant stack nonetheless behaves like a zero-priced conversion instrument, and the pre-existing warrant tranche at a $32.40 weighted-average strike is deep out of the money and low risk absent a repricing (though management repriced warrants in a December 2025 inducement, so that precedent exists).

Share Structure

Float to Fully Diluted Breakdown

LIKELY STALE

Reported float from Insight Sentry (as-of date unknown; pre-split). Adjusted based on SEC filing analysis.

Float Discrepancy: our SEC analysis shows 513K vs 695K reported — overstated 35%

Insight Sentry reports float of 2,563,149 and shares outstanding of 16,247,846 — both pre-split artifacts. 16,247,846 is exactly 5x the 2026-07-23 pre-split cover count of 3,249,569, and the reported market cap of $10.83M against a $3.52 post-split price implies roughly 3.08M shares, none of which is internally consistent. The feed has NOT processed the 1-for-5 reverse split effective 2026-07-31, ...

Reported Float695K21.8%
Warrants2.51M79.0%
pre-funded951K shares at $0.005
common1.13M shares at $3.55
placement_agent45K shares at $3.55
common391K shares at $32.4
Other1320.0%
Options / RSUs132 shares
≈ Estimated Actual Float

Reported float + filing adjustments

513K

MEDIUM confidence

Pending Shares as % of Float493.8%

Registered and convertible shares that could enter the float relative to current float size.

Fully Diluted3.18M100%

Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue
Dilution profile
Reverse splits (6)
  • 1-for-5·Aug 4, 2026this month
  • 1-for-10·Oct 20, 2025~10 mo ago
  • 1-for-8·Jun 9, 2025~1 yr ago
  • 1-for-10·Oct 5, 2023~3 yr ago
  • 1-for-15·Oct 15, 2019~7 yr ago
  • 1-for-50·Apr 14, 2015~11 yr ago
Active mechanisms
  • Pre-funded warrants at $0.005 post-split (~950,800 shares) — exercisable now, registered, no approval required, actively being exercised
  • Residual December 2025 pre-funded warrants at ~$0.0005 post-split (~50,800 shares) — registered for resale under S-1 333-292598
  • 1,126,602 common warrants at $3.55 (at-the-money) unlocking on Stockholder Approval, meeting deadline 2026-10-01
  • 45,064 placement agent warrants at $3.55, exercisable from ~2027-01-07
  • ATM facility with ~$542,716 remaining capacity under baby-shelf General Instruction I.B.6 (currently constrained by a 90-day issuer lock-up running to approximately 2026-10-05)
  • 391,498 pre-existing warrants at a $32.40 weighted-average strike — inert unless repriced, but a December 2025 inducement repricing precedent exists
  • 17,452 post-split RSUs and 26,422 post-split shares reserved under the equity incentive plan

Market Data

Price

$2.17

Market Cap

$1.84M

Outstanding

711.1K

Float

694.6K

Avg Volume

1.70M

Exchange: NASDAQ|Source: Insight Sentry